Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM N.V.    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Amsterdam
02/22/2021 02/23/2021 02/24/2021 02/25/2021 02/26/2021 Date
141.1(c) 139.9(c) 138(c) 138.7(c) 136.55 Last
362 216 413 866 362 111 304 320 535 857 Volume
-0.91% -0.85% -1.36% +0.51% -1.55% Change
More quotes
Financials
Sales 2020 8 439 M 10 223 M 10 223 M
Net income 2020 654 M 793 M 793 M
Net Debt 2020 2 831 M 3 430 M 3 430 M
P/E ratio 2020 37,5x
Yield 2020 1,80%
Sales 2021 8 715 M 10 559 M 10 559 M
Net income 2021 918 M 1 112 M 1 112 M
Net Debt 2021 1 046 M 1 267 M 1 267 M
P/E ratio 2021 24,7x
Yield 2021 1,85%
Capitalization 23 520 M 28 753 M 28 494 M
EV / Sales 2020 3,12x
EV / Sales 2021 2,82x
Nbr of Employees 23 127
Free-Float 94,7%
More Financials
Company
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions) by... 
Sector
Diversified Chemicals
Calendar
05/05 | 01:00amEarnings Release
More about the company
All news about ROYAL DSM N.V.
09:07aROYAL DSM N : DSM announces price increase for polyamide 6 and 66 compounds in E..
PU
02/23KONINKLIJKE PHILIPS N : Philips Names New Supervisory Board Chairman, Vice Chair..
MT
02/23KONINKLIJKE PHILIPS N : Philips Chairman, Vice Chair to Retire in May; Successor..
MT
02/23KONINKLIJKE PHILIPS N : Philips Says Both Supervisory Board Chairman, Vice Chair..
DJ
02/16GLOBAL MARKETS LIVE: CVS Health, Dentsu, Glencore…
02/16ROYAL DSM N : DSM Forecasts 'Positive' 2021 After Reporting Mixed 2020 Results
MT
02/16ROYAL DSM N : 2015 (pdf)
PU
02/16ROYAL DSM N : DSM's FY20 Profit Declines As Revenue Increases On Good Results In..
MT
02/16ROYAL DSM N : DSM reports 2020 results
PU
02/15ROYAL DSM N : DSM announces price increases for Dyneema® and Trosar™
PU
02/05ROYAL DSM N : DSM partners with Sympatex Technologies to launch mass-balanced bi..
PU
01/28ROYAL DSM N : Fonterra joins forces with DSM to lower carbon footprint
PU
01/28ROYAL DSM N : Major reduction of greenhouse gas emissions from dairy cows proven..
PU
01/21ROYAL DSM N : DSM launches its sustainability platform ‘Reducing emissions..
PU
01/07ROYAL DSM N : DSM and Clariter partner to pursue chemical recycling solution for..
PU
More news
News in other languages on ROYAL DSM N.V.
01:18aABB : Matti Alahuhta renonce à solliciter un nouveau mandat d'administrateur
02/23JEROEN VAN DER VEER : Feike Sijbesma nouveau président du conseil
02/23FEIKE SIJBESMA : Ehemaliger DSM-Chef Feike Sijbesma wird Aufsichtsratschef von P..
02/23KONINKLIJKE PHILIPS N : Bei Philips Wechsel im Aufsichtsrat nach der Hauptversam..
02/16DSM : baisse de 34% du bénéfice net en 2020
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 150,37 €
Last Close Price 138,70 €
Spread / Highest target 29,8%
Spread / Average Target 8,42%
Spread / Lowest Target -43,8%
EPS Revisions
Managers and Directors
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.-1.49%28 753
BASF SE5.32%76 532
SHIN-ETSU CHEMICAL CO., LTD.0.47%70 871
DUPONT DE NEMOURS, INC.-1.91%37 532
EVONIK INDUSTRIES AG4.80%15 900
ASAHI KASEI CORPORATION10.29%15 188